The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it binds with an androgen hormone or an antiandrogen drug, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
from The Medical News http://ift.tt/1BwsX8T
from The Medical News http://ift.tt/1BwsX8T
No comments:
Post a Comment